Literature DB >> 18025783

Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II.

Pauline Aalten1, Frans R J Verhey, Marina Boziki, Andrea Brugnolo, Roger Bullock, Eleanor Jane Byrne, Vincent Camus, Miriam Caputo, Debby Collins, Peter Paul De Deyn, Kazi Elina, Giovanni Frisoni, Clive Holmes, Catherine Hurt, Anna Marriott, Patrizia Mecocci, Flavio Nobili, Pierre Jean Ousset, Emma Reynish, Eric Salmon, Magda Tsolaki, Bruno Vellas, Philippe H Robert.   

Abstract

BACKGROUND/AIMS: The aim of this study was to determine the consistency of neuropsychiatric subsyndromes of the Neuropsychiatric Inventory across several clinical and demographic subgroups (e.g. dementia subtypes, dementia severity, medication use, age and gender) in a large sample of outpatients with dementia.
METHODS: Cross-sectional data of 2,808 patients with dementia from 12 centres from the European Alzheimer's Disease Consortium were collected. Principal component analysis was used for factor analysis. Subanalyses were performed for dementia subtypes, dementia severity, medication use, age and gender.
RESULTS: The results showed the relatively consistent presence of the 4 neuropsychiatric subsyndromes 'hyperactivity', 'psychosis', 'affective symptoms' and 'apathy' across the subanalyses. The factor structure was not dependent on dementia subtypes, age and gender but was dependent on dementia severity and cholinesterase use. The factors hyperactivity and affective symptoms were present in all subanalyses, but the presence of the factors apathy and psychosis was dependent on use of cholinesterase inhibitors and dementia severity, respectively.
CONCLUSION: The present study provided evidence of the relative consistency of neuropsychiatric subsyndromes across dementia subtypes, age and gender, thereby stressing the importance of thinking about neuropsychiatric subsyndromes instead of separate symptoms. However, the subsyndromes apathy and psychosis were dependent on use of cholinesterase inhibitors and dementia severity. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18025783     DOI: 10.1159/000111082

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  41 in total

1.  Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Linda Ferrington; J Scott Miners; Laura E Palmer; Susan M Bond; Joanne E Povey; Paul At Kelly; Seth Love; Karen J Horsburgh; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2011-02-05       Impact factor: 4.060

2.  Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons.

Authors:  Tau Ming Liew
Journal:  J Am Med Dir Assoc       Date:  2019-03-26       Impact factor: 4.669

3.  [Antipsychotics for treatment of neuropsychiatric disorders in dementia].

Authors:  H-J Gertz; G Stoppe; B Müller-Oerlinghausen; L G Schmidt; C Baethge; C Hiemke; K Lieb; T Bschor
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

Review 4.  [Therapy of psychological and behavioral symptoms in dementia].

Authors:  F Jessen; A Spottke
Journal:  Nervenarzt       Date:  2010-07       Impact factor: 1.214

5.  The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.

Authors:  Brendan J Guercio; Nancy J Donovan; Catherine E Munro; Sarah L Aghjayan; Sarah E Wigman; Joseph J Locascio; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients.

Authors:  B Guarnieri; F Adorni; M Musicco; I Appollonio; E Bonanni; P Caffarra; C Caltagirone; G Cerroni; L Concari; F I I Cosentino; S Ferrara; S Fermi; R Ferri; G Gelosa; G Lombardi; D Mazzei; S Mearelli; E Morrone; L Murri; F M Nobili; S Passero; R Perri; R Rocchi; P Sucapane; G Tognoni; S Zabberoni; S Sorbi
Journal:  Dement Geriatr Cogn Disord       Date:  2012-03-08       Impact factor: 2.959

Review 7.  Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease.

Authors:  Lezanne Ooi; Kuldip Sidhu; Anne Poljak; Greg Sutherland; Michael D O'Connor; Perminder Sachdev; Gerald Münch
Journal:  J Neural Transm (Vienna)       Date:  2012-06-13       Impact factor: 3.575

8.  Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.

Authors:  Paula T Trzepacz; Andrew Saykin; Peng Yu; Phani Bhamditipati; Jia Sun; Ellen B Dennehy; Brian Willis; Jeffrey L Cummings
Journal:  Am J Geriatr Psychiatry       Date:  2013-04-18       Impact factor: 4.105

9.  Neural correlates of apathy revealed by lesion mapping in participants with traumatic brain injuries.

Authors:  Kristine M Knutson; Olga Dal Monte; Vanessa Raymont; Eric M Wassermann; Frank Krueger; Jordan Grafman
Journal:  Hum Brain Mapp       Date:  2013-02-13       Impact factor: 5.038

10.  Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours.

Authors:  J M Haro; K Kahle-Wrobleski; G Bruno; M Belger; G Dell'Agnello; R Dodel; R W Jones; C C Reed; B Vellas; A Wimo; J M Argimon
Journal:  J Nutr Health Aging       Date:  2014-07       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.